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Abstract
Background: The 2007 World Health Organization (WHO) guideline to diagnose smear-negative tuberculosis (TB) in
HIV-prevalent settings was mainly based on expert advice and therefore requires evaluation in real life situations.
Methods: In 2009, this guideline was introduced at the ALERT hospital in Ethiopia. From October 2009 to January
2011, the accuracy of the guideline was evaluated using Mycobacterium tuberculosis culture positivity as reference
standard in HIV positive TB suspects.
Results: A total of 459 TB suspects were enrolled during the study period; 336 (73.2%) were HIV positive. Acid fast
bacilli sputum smear microscopy was done for 74.7% (251/336) HIV positive TB suspects; 94.4% (237/251) were
smear negative. A chest X-ray was performed in 92.8% (220/237) and a Mycobacterium tuberculosis culture in 63.7%
(151/237). The median TB diagnostic delay for smear negative cases was 3 days (interquartile range 3–4 days). Of
the 75 patients diagnosed with smear negative pulmonary TB, 89. 4% (67/75) were diagnosed by chest X-ray, 9.4%
(7/75) by culture and 1.3% (1/75) by clinical suspicion only. In 147 smear negative TB suspects Mycobacterium
tuberculosis culture and chest X-ray results were available. Among these 147 patients, the sensitivity of the chest
X-ray to diagnose smear negative TB in HIV-positive TB suspects was 53.3% (95% CI: 26.7-78.7); the specificity 67.4%
(95% CI: 58.7-75.3).
Conclusion: The 2007 WHO diagnostic algorithm for the diagnosis of smear negative TB is likely to reduce the
diagnostic delay and therefore decrease morbidity and mortality of TB in a HIV prevalent settings like Ethiopia.
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Background
The WHO has classified Ethiopia among the 22 high
burden countries with TB. In 2011, it was estimated that
in Ethiopia the annual TB incidence was 258/100,000,
the prevalence of all forms of TB 237/100,000 and the
TB mortality rate 18/100,000 [1].
In 2011 the adult HIV prevalence in Ethiopia was 1.5%
[2] and the prevalence of HIV in newly diagnosed pa-
tients with TB 17% [1]. TB and HIV co-infection pre-
sents special diagnostic and therapeutic challenges and
constitutes an immense burden on healthcare systems of
countries with high prevalence [3-5]. In patients with
HIV, especially patients with low CD4 T cell counts, TB
is more difficult to diagnose because they often present
with smear negative pulmonary TB and extrapulmonary
TB [6]. This contributes to low case detection rates [7]
and TB diagnosis delay. Therefore, in September 2005,
WHO convened an expert group to review the 2003
WHO recommendations concerning the diagnosis of
smear-negative TB in HIV-prevalent settings.
Major changes were proposed. In 2007 a new diagnos-
tic algorithm was endorsed. The new recommendations
included: all TB suspects need to be tested for HIV, in
HIV positive individuals only two sputa (spot-morning)
need to be obtained and one positive smear is enough to
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diagnose TB; a chest X-ray and Mycobacterium tubercu-
losis cultures should be performed if smears are negative
and an antibiotic trial should not be done as a diagnostic
test [8].
In Ethiopia, the new WHO diagnostic algorithm was
adopted by the end of 2009. The adult HIV prevalence
in Addis Ababa during the 2010 was 5.2% [2]. The ob-
jective of this study was to evaluate the operational per-
formance of the 2007 WHO diagnostic algorithm to
diagnose smear negative TB in HIV-positive patients in a
tertiary referral hospital in Addis Ababa.
Methods
Setting and design
From October 2009 to January 2011, we evaluated the
operational performance of the WHO 2007 smear nega-
tive TB diagnostic algorithm at the ALERT hospital. The
ALERT hospital is located in Addis Ababa. It is equipped
with a TB culture facility. Prior to the implementation of
the study, all health professionals (doctors, nurses,
laboratory and X-ray technicians) involved in TB/HIV
services were trained during one week about the 2007
WHO guideline. One local physician was appointed to
supervise the research activities. Monthly supervisions
to the hospital were done by the investigators.
TB suspects, 15 years or older, were enrolled. Patients
were considered TB suspects according to WHO criteria
[8] if they presented with cough for at least 2 weeks or
weight loss with night sweats or feeling feverish with
T>37.5°C, breathlessness due to pleural effusion or peri-
carditis or enlarged (>2 cm) glands in neck or armpits.
Patients with danger signs (defined by WHO [8]) were
excluded.
In TB suspects with enlarged peripheral lymph nodes
fine needle aspiration (FNA) was performed using a
22-gauge needle attached to a 10-cc syringe. Aspirates
were macroscopically evaluated for caseation and smears
were air dried, stained with Wright stain and examined
cytologically by a pathologist. Cytology was considered
to be diagnostic for TB in the presence of epitheloid cell
granulomas and caseous necrosis with or without
Langhans giant cells [9,10].
Sputum samples from TB suspects that were negative
by AFB microscopy were cultured for the presence of
Mycobacterium tuberculosis complex by Löwenstein-
Jensen (LJ) slants (but only one culture per patient was
performed). The samples were processed by the standard
N-acetyl L-cysteine (NALC)-NaOH method [11] and
concentrated at 3000 g for 15 minutes. Sediments were
reconstituted to 2.5 ml with phosphate buffer pH 6.8, to
make the inoculums for the cultures. Two Lowenstein-
Jensen slants, one containing 0.75% glycerol and the
other containing 0.6% pyruvate, were inoculated with
the sediment and incubated at 37°C. Cultures were
considered negative when no colonies were seen after
8 weeks of incubation.
The following TB case definitions were used as indi-
cated in the WHO 2007 guideline [8]. 1) Smear-positive
pulmonary tuberculosis- One sputum smear examin-
ation positive for acid-fast bacilli (AFB) AND- laboratory
confirmation of HIV infection OR strong clinical evi-
dence of HIV infection. 2) Smear-negative pulmonary
tuberculosis- At least two sputum specimens negative
for AFB AND radiographical abnormalities consistent
with active tuberculosis AND- laboratory confirmation
of HIV infection OR strong clinical evidence of HIV
infection AND decision by a clinician to treat with a full
course of antituberculosis chemotherapy OR a patient
with AFB smear-negative sputum which is culture-positive
for Mycobacterium tuberculosis. 3) Extrapulmonary
tuberculosis- One specimen from an extrapulmonary site
culture-positive for Mycobacterium tuberculosis or smear-
positive for AFB OR histological or strong clinical evi-
dence consistent with active extrapulmonary tuberculosis
AND- laboratory confirmation of HIV infection OR
strong clinical evidence of HIV infection AND a decision
by a clinician to treat with a full course of antituberculosis
chemotherapy.
All consenting TB suspects were offered HIV testing
and counseling. HIV testing was done according to
the Ethiopian national guidelines. HIV screening was
performed using the KHB test (Shanghai Kehua Bio-
Engineering Ltd, Shanghai, China; 2008). A positive sam-
ple was retested using the STAT-PAK test (Chembio
Diagnostic System Inc, Medford, NY, USA; 2008).
Uni-Gold (Trinity Biotech PLC, Ireland) was used as a
tiebreaker.
Data analysis
Data were double entered using EpidData software ver-
sion 3.1(EpidData, Norway, 2006). For analysis, the data
were exported to SPSS version 15.0 statistical software
(SPSS Inc. Chicago, 2007). Descriptive analysis was done
to depict the TB suspects’ characteristics. The incremen-
tal yield of the different investigations was defined as the
proportion of patients additionally diagnosed by X-ray if
smear-negative, by clinical suspicion in smear-negatives
without an X-ray abnormality consistent with active TB,
and ultimately by culture if all of the above were nega-
tive. Health system diagnostic delay (time between first
presentation at the clinic and date of diagnosis) was cal-
culated for all patients. Sensitivity and specificity of the
chest X-ray was calculated using Mycobacterium tuber-
culosis culture positivity as reference standard. Patients
without X-ray or culture results were excluded from this
analysis. Confidence intervals around sensitivity and spe-
cificity were calculated using the Wilson’s method.
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Ethical considerations
The study protocol was approved in Ethiopia by
the ethical review committees of Jimma University,
Armauer Hansen Research Institute and Ministry of
Science and Technology. In Belgium it was approved
by the ethical review committees of the Institute of
Tropical Medicine and the University hospital of
Antwerp. Written consent was obtained from the
study participants.
Results
Patient characteristics
A total of 459 TB suspects were screened. The median
age of the TB suspects was 35 years (interquartile range
30–45 years); 55.1% (253/459) were females. The major-
ity of the TB suspects were urban residents (98.3% (451/
459), had cough since at least 2 weeks (91.1% (418/459))
and were HIV positive (73.2% (336/459)). Among the
HIV positive TB suspects 88.7% (298/336) had cough
Table 1 TB suspects characteristics by HIV status
Characteristics All TB suspects HIV positive TB suspects P-value
TB suspects, n 459 (100.0) 336 (73.2) <0.001
Age in years, Median (IQR) 35 (30.0–45.0) 35 (29.3–42.0)
Female sex, n (%) 253 (55.1) 194 (57.7) 0.06
Urban resident, n (%) 451 (98.3) 334 (99.4) 0.02
Symptoms
Cough for 2 weeks or more, n (%) 418 (91.1) 298 (88.7) 0.03
Weight loss, n (%) 236 (51.4) 188 (56.0) 0.001
Fever, n (%) 293 (63.8) 195 (58.0) <0.01
Current shortness of breath, n (%) 168 (36.5) 102 (30.4) <0.001
Lymph node swelling, n (%) 49 (10.7) 45 (13.4) 0.002
HIV positive TB suspects n=336
AFB smear microscopy done n= 251(84.2% )
Smear  positive n=14 (5.6%) Smear  negative n= 237(94.4%)
X-rays and culture  ordered n= 151 (63.7%) † Only X-rays ordered n= 69(29.1%) 
Cough for >=2 weeks n= 298(88.7%)
Figure 1 Flow of the diagnostic process in HIV positive TB suspects at the ALERT hospital, Addis Ababa, Ethiopia. † four culture results
were not available (2 contaminated and 2 not done).
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since at least 2 weeks. Other symptoms reported in-
cluded weight loss (56.0% (188/336)), fever (58.0% (195/
336)), shortness of breath (30.4% (102/336)) and lymph
node swelling (13.4% (45/336)) (Table 1).
Operational performance
Diagnostic workup
Sputum AFB microscopy was done for 84.2% (251/298)
of the HIV positive TB suspects with cough of two
weeks or more. 94.4% (237/251) were sputum AFB
smear negative. A chest X-ray was performed in 92.8%
(220/237) and a Mycobacterium tuberculosis culture was
ordered in 63.7% (151/237) of the smear negative TB
suspects. A chest X-ray was performed in all TB sus-
pects with a Mycobacterium tuberculosis culture. Four
culture results were not available (2 contaminated, 2 not
done) (Figure 1).
Diagnostic outcomes of TB suspects and diagnostic delay
Of the 336 HIV positive TB suspects, 36.6% (123/336)
were diagnosed with TB: 11.4% (14/123) smear positive
pulmonary TB, 61.0% (75/123) smear negative pulmo-
nary TB, 19.5% (24/123) TB lymphadenitis and 8.1%
(10/123) other forms of TB. Mycobacterium tuberculosis
culture was positive in 10.2% (15/147) and a chest X-ray
result was consistent with active TB in 35.0% (77/220) of
the smear negative TB suspects. The median diagnostic
delay for smear negative pulmonary TB cases was 3 days
(interquartile range 3–4 days). The median number of
visits before the diagnosis of smear negative TB was 2
(Table 2).
Incremental yield of the different investigations
Of the 123 patients diagnosed with TB, 11.4% (14/123)
were diagnosed by AFB smear microscopy, 18.7% (23/
123) by FNA cytology, 62.6% (77/123) by chest X-ray,
5.7% (7/123) by culture and 1.6% (2/123) by clinical sus-
picion only. Of the 75 patients diagnosed with smear
negative pulmonary TB, 89. 4% (67/75) were diagnosed
by chest X-ray, 9.4% (7/75) by culture and 1.3% (1/75)
by clinical suspicion only (Table 3).
Diagnostic accuracy of the chest X-ray to diagnose smear
negative TB
Of the HIV positive smear negative TB suspects, in 151
a Mycobacterium tuberculosis culture was ordered and
in 147 a culture result obtained (Table 4). Among these
147 patients the sensitivity of the chest X-ray was 53.3%
(95% CI: 27.7-78.7) and the specificity 67.4% (95%
CI: 58.7-75.3). The positive predictive value was 15.7%
(95% CI: 7.1-28.6) and the negative predictive value
92.7% (95% CI: 85.6-97.0).
Discussion
Since the WHO 2007 guideline for the diagnosis of
smear negative TB was largely based on expert opinion,
validation was required. A randomized controlled trial
comparing the WHO 2003 with the 2007 guidelines was
considered to be unethical. Therefore we were only able
to evaluate the 2007 guidelines during its implementa-
tion in an urban reference hospital in Ethiopia.
Table 2 Diagnostic outcomes of HIV positive TB suspects
(n=336)
Outcome N(%)
Diagnosed with TB 123 (36.6)
Type of TB (n=123)
Smear Positive pulmonary TB 14 (11.4)
Smear Negative Pulmonary TB 75 (61.0)
TB Lymphadenitis 24 (19.5)
Other forms of TB 10 (8.1)
Positive culture result (n=147)# 15 (10.2)
X-ray result consistent with active TB (n=220)# 77 (35.0)
WHO stage for co-infected patients
III 89 (72.4)
IV 34 (27.6)
Median diagnostic delay in days (IQR) 3 (3–4)
Median number of visits before smear negative TB
diagnosis
2
#Smear negative TB suspects, IQR interquartile range.
Table 3 Incremental yield of the 2007 guideline in HIV
patients with all forms of TB and smear negative
pulmonary TB
Method All patients with
TB-HIV co infection
(n=123)
HIV patients with smear
negative pulmonary TB
(n=75)
AFB sputum
smear
microscopy
14 (11.4%) NA
FNA cytology +23 (18.7%) NA
Clinical
suspicion
+2 (1.6%) +1 (1.3%)
Chest X- ray +77 (62.6%) +67 (89.3%)
Culture +7 (5.7%) +7 (9.4%)
NA Not applicable.
Table 4 Comparison of the chest X-ray to diagnose smear
negative TB with culture in HIV positive patients
Chest X-ray Culture result
Positive Negative
Consistent with TB 8 43
Not consistent with TB 7 89
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Our study suggests that the 2007 diagnostic algorithm
may reduce the health system related diagnostic delay of
smear negative TB. Indeed, before the introduction of
the new guideline Demissie et al. reported a diagnostic
delay of 6 days in all public health centers in Addis
Ababa [12]. Despite the fact that the latter study was
done in other health centers in Addis Ababa and did not
report separately for HIV positive TB patients, the differ-
ence is striking (only 3 days in our study). At the
Nekemte referral hospital in the west part of Ethiopia,
which was still implementing the 2003 guideline during
our study period, the median diagnostic delay for smear
negative TB cases was even 14 days (Gemeda Abebe,
personal communication). Delay in TB diagnosis is an
important contributor of excess morbidity and mortality
in HIV-infected people [13,14]. Delay in TB diagnosis is
particularly problematic in HIV-infected individuals be-
cause in those patients TB presents more commonly as
a disseminated disease [15] and disease progression is
more rapid [16]. In our study the median number of
visits by patients before a diagnosis of smear negative
TB diagnosis was made was 2. According to the WHO
2007 guideline the total number of visits should not be
more than 4 [8].
A high number of smear negative TB cases (89.3% of
smear negative pulmonary TB cases) were diagnosed on
the basis of X-ray results. This is similar to a study in
Cambodia where 50.5% of the HIV positive TB cases
were diagnosed on the basis of radiology [17]. The diag-
nostic sensitivity of the chest X-ray in our study was
53.3% (95% CI: 27.7-78.7). This result is comparable with
reports from India (72%) [18], Kenya (55%) [19] and
Uganda [20]. The specificity of 67.4% in our study is
similar to the report from Kenya (72.9%) [19] but higher
than the report from Uganda (22%) [20]. The chest
X-ray had excellent negative predictive value but poor
positive predictive value. Culture contributed to an add-
itional diagnosis of only 7 cases (11.9%) of the smear
negative TB. It is evident that we need diagnostic tools
with a shorter turnaround time than culture. In a study
in South Africa the GeneXpert MTB/RIF assay increased
the case detection rate by 45% [21]. However, in re-
source limited settings like Ethiopia where GeneXpert
MTB/RIF is only available in a few research sites, the
2007 WHO guideline for the diagnosis of smear negative
TB is still relevant. FNA cytology contributed to the
diagnosis of an additional 23 (18.7%) TB cases.
Our study has several limitations. Firstly, it was a sin-
gle center based study; as a result the performance of
the guideline at different levels of HIV and TB preva-
lence could not be evaluated. Secondly, we were unable
to directly compare the performance of the new with the
old WHO guidelines. Thirdly, due to the fact that not all
TB suspects with cough were able to produce sputum
with required quantity and quality, in an appreciable
number of TB suspects no AFB or culture results were
obtained. Finally, the solid culture used as reference
standard for detecting TB may have under estimated the
culture positivity rate. Culturing multiple specimens on
liquid media would have detected more TB cases [22-24]
and may have influenced the accuracy of chest X-ray.
The value of our study lies in the description of the
operational benefits of the new guidelines in a real life
situation in a high HIV prevalent setting.
Conclusion
The 2007 WHO diagnostic algorithm for the diagnosis
of smear negative TB is likely to reduce the diagnostic
delay and therefore decrease morbidity and mortality of
TB in a HIV prevalent settings like Ethiopia.
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